Halda Therapeutics
New Haven, US · Founded 2018 · Delaware LLC
Biotech
Founders & leadership
SP
Scott PhillipsExecutive Officer
TS
Tim ShannonManager
LR
Liam RatcliffeManager
LW
Leyi WangManager
RF
Rebecca FreyManager
Reported raises · per SEC filings
Form D private placements▶$126.5MraisedAug 2024 · 20 investors · Other Health CareRule 506(b)
Officers, directors & promoters on the filing
- Liam RatcliffeDirector
- Nandita ShangariDirector
- Tim ShannonExecutive Officer, Director
- Joe CabralDirector
- Rebecca FreyDirector
- Rebecca LuseDirector
- Arjun GoyalDirector
- Scott PhillipsExecutive Officer
- Offering amount
- $126.5M
- Amount sold
- $126.5M
- First sale
- Jul 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedMay 2024 · 9 investors · Other Health CareRule 506(b)
Officers, directors & promoters on the filing
- Liam RatcliffeDirector
- Rebecca FreyDirector
- Tim ShannonExecutive Officer, Director
- Scott PhillipsExecutive Officer
- Offering amount
- $36M
- Amount sold
- $24.2M
- First sale
- May 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$41MraisedDec 2021 · 11 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Liam RatcliffeDirector
- Leyi WangDirector
- Rebecca FreyDirector
- Offering amount
- $51M
- Amount sold
- $41M
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$6.3MraisedMar 2019 · 12 investors · Other Health CareRule 506(b)
Officers, directors & promoters on the filing
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Wei ZhaoDirector
- Offering amount
- $25.1M
- Amount sold
- $6.3M
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.